Study on the Effect of 40 Hz Non-Invasive Light Therapy System

Recruiting N/A Interventional Study
Alzheimer's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
62 (estimated)
Sponsor
Zealand University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Invisible Spectral Flicker is a potential therapy for Alzheimer's Disease. In order to examine this, 62 patients with mild …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult competent person, able to understand the nature of the study and give written informed consent. * Diagnosed with probable mild to moderate AD based on NIA-AA diagnostic criteria or in a prodromal stage of AD with at least one positive biomarker of AD. * Age \> 40 years. …
Contacts

Peter Høgh, MD, Phd

47322809

phh@regionsjaelland.dk

CONTACT

Maibritt Horning, MSc

+45 81949649

maibho@regionsjaelland.dk

CONTACT